Stonehenge Partners Corp

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Stonehenge Partners Corp
CRD #333491
SEC #802-131608
CIK #0001638279
AUM
Employees
Phone614-246-2500
Address191 W Nationwide Blvd
Columbus, OH 43215
Source [IAPD] [EDGAR] [Website]
Total AUM ($)
1.00.80.60.40.20.02011201620212026
Type Form D Funds Date Sold ($M) AUM ($M)
PE Stonehenge Opportunity Fund III-B LP 2024-11-11 6.5
PE Stonehenge Opportunity Fund III LP 2024-11-11 39.6
Other Stonehenge Opportunity Fund IV LP [2024-11-11] 81.5 266.2
Other Stonehenge Opportunity Fund V LP [2024-11-11] 139.1 281.3
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors # Filings # Firms 2011 - 2025
Peter Davies 19
David Meuse 13
Thomas Utgard 2
Robert Eversole 2
Corp Stonehenge Partners 1
Stephen Kimpel 1
Michael Endres 1
Stonehenge Equity Partners V 1
Andrew Bohutinsky 1
EDGAR Form CIK 2011 - 2025
3 [0001638279]
4 [0001638279]
SC 13G [0001638279]
Form 13D/13G Filer Form 13D/13G Subject Filed
Stonehenge Partners LLC Ritter Pharmaceuticals Inc [2016-02-25]
Form 3/4/5 Subject 2011 - 2025
Stonehenge Partners LLC
Qualigen Therapeutics, Inc.
Terms | Privacy | Guide
tony@aum13f.com